Stage	TNM	5-year Survival	Cases
0	Carcinoma in situ
IA	T1N0M0	67%	[1], [2]
IB	T2N0M0	57%	[1]
IIA	T1N1M0	55%	[1]
IIB	T2N1M0 T3N0M0	38%	[1]
IIIA	T3N1M0 T1N2M0 T2-3N2M0	23%	[1]
IIIB	T4N0-2 T1-4N3M0	5%	[1], [2]
IV	T1-4N0-3M1	1%	[1], [2]